Company / PP&E (Net)
STAAR Surgical Company PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$73.3M
FY2025
5-year range
$35.9M / $84.9M
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#91 of 132
Health Care
What the data says
At $73M, STAAR Surgical Company's pp&e (net) ranks #91 of 132 in the Health Care sector. Improved from $67M to $73M over the past 2 years.
Based on SEC 10-K filings.
$73M in FY2025 with a 5-year CAGR of +25.0%.
Improved from $67M to $73M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
#91 of 132 in Health CareTop 69% of 132This company $73.3M Sector average $1.4B
▼
-94.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 13.6% year-over-year.
- Ranks #91 out of 132 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.3M | -13.6% |
| FY2024 | $84.9M | +27.0% |
| FY2023 | $66.8M | +31.3% |
| FY2022 | $50.9M | +41.8% |
| FY2021 | $35.9M | +49.4% |
| FY2020 | $24.0M | +40.8% |
| FY2019 | $17.1M | +49.0% |
| FY2018 | $11.5M | +17.1% |
| FY2017 | $9.8M | -17.1% |
| FY2016 | $11.8M | +16.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026